Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis

Cholesterol Treatment Trialists' (CTT) Collaborators · 2008 · The Lancet

Abstract

Background Although statin therapy reduces the risk of occlusive vascular events in people with diabetes mellitus, there is uncertainty about the effects on particular outcomes and whether such effects depend on the type of diabetes, lipid profile, or other factors. We undertook a prospective meta-analysis to help resolve these uncertainties. Methods We analysed data from 18 686 individuals with diabetes (1466 with type 1 and 17,220 with type 2) in the context of a further 71,370 without diabetes in 14 randomised trials of statin therapy. Weighted estimates were obtained of effects on clinical outcomes per 1.0 mmol/L reduction in LDL cholesterol. Findings During a mean follow-up of 4.3 years, there were 3247 major vascular events in people with diabetes. There was a 9% proportional reduction in all-cause mortality per mmol/L reduction in LDL cholesterol in participants with diabetes (rate ratio [RR] 0.91, 99% CI 0.82-1.01; p=0.02), which was similar to the 13% reduction in those without diabetes (0.87, 0.82-0.92; p Interpretation Statin therapy should be considered for all diabetic individuals who are at sufficiently high risk of vascular events.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(08)60104-x

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

22 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. 2000, Ital Heart J, 1, 810

Cited by

See all 2,081

Metadata

Authors
Collaborators, C. T. T. (.
Affiliations
University of Oxford (GB)
Corresponding author
Cholesterol Treatment Trialists' (CTT) Collaborators
Venue
The Lancet
Publisher
Elsevier BV
Published
2008-01
Volume
371
Issue
9607
Pages
117-125
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2097870088
Cited by
2,081
References
46
Citations by year
2026: 54 · 2025: 72 · 2024: 86 · 2023: 117 · 2022: 79 · 2021: 99 · 2020: 119 · 2019: 122 · 2018: 107 · 2017: 125 · 2016: 118 · 2015: 132 · 2014: 133 · 2013: 154 · 2012: 137
FWCI
23.65
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
  • Cancer Research UK
  • British Heart Foundation
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
statins, diabetes mellitus, LDL cholesterol lowering, type 1 diabetes, type 2 diabetes, major vascular events, all-cause mortality, vascular death, myocardial infarction, coronary revascularization, stroke, hypercholesterolemia, cardiovascular risk reduction, lipid-lowering therapy, coronary artery disease, stroke prevention, cardiovascular risk stratification
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Cholesterol, LDL, Male, Middle Aged, Triglycerides, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(08)60104-x
The paper
Collaborators, C. T. T. (. (2008). Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. The Lancet. https://doi.org/10.1016/s0140-6736(08)60104-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.